Background and Key Drivers Leading to Clinical Immunogenicity
Dr Matthew Baker, Chief Scientific Officer at Antitope Ltd, speaking at Bioprocessing, Biologics and Biotherapeutics 2011.
Improving on Rituximab – Selecting CD20 mAb for the Future
Professor Mark Cragg, Southampton University, speaking at BioProcessing, Biologics & Biotherapeutics Congress Europe 2011.
Antibody Fragments - New Approaches for Production
Dr John Lidell, FujiFilm, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.
New Tools for Flexible Manufacturing of Monoclonal Antibodies
In this webinar, Dr. Jagschies discusses new tools for flexible manufacturing.
Progression of HCV Infection to Hepatocellular Carcinoma
Radoslav Goldman, Associate Professor, Georgetown University, speaking at European Biomarkers Summit 2010.
Procalcitonin (PCT) Webinar - How to Incorporate Procalcitonin (PCT) into your Facility's Sepsis Initiative
In this webinar Kirsten R. Pyle-Springer, Sepsis Coordinator at Surgical/Neuro/Trauma Intensive Care Unit, Mission Hospital in Mission Viejo, California discusses the Awareness of Sepsis and the risk of Sepsis in critical care settings.
Sensitive and High Throughput Multiplexed Immunoassays for Biomarker Discovery in Biobanked Samples Using Proximity Ligation Assays and qPCR
Simon Fredriksson, Chief Scientific Officer, Olink Bioscience, speaking at European Biomarkers Summit 2009
Immunoprofiling of Cancer-Specific Antibodies on Protein Microarrays of Novel Tumor Antigens
Michael Tainsky, Professor, Wayne State University, speaking at Microarray World Congress 2009
|<< || 1 2 3 4 ||>>|
|Showing Results 31 - 38 of 38|